Mumbai-based healthtech startup Wellthy Therapeutics has raised $4 Mn in its Pre-Series A funding round from Saama Capital. As part of this deal, Saama Capital has received a 16% stake in the company. Managing partner at Saama Capital Suresh Shanmugham will also join Wellthy’s board. With the funds, Wellthy Therapeutics will enhance its product suite to enhance user experience on the platform. The startup is also planning to add more therapy categories and grow its international business.
Wellthy Therapeutics Raises $4 Mn From Saama Capital To Enhance Product Suite
Date posted: Wednesday 6 May 2020